Stay updated on Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.

Latest updates to the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a new release of the page; the underlying study details remain unchanged.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedClinicalTrials.gov’s page revision/version label was updated from v3.5.2 to v3.5.3 without any visible change to the study details themselves.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to study details.SummaryDifference0.0%

- Check45 days agoChange DetectedTwo keywords were added to the study's keyword list: Small cell lung carcinoma and Cutaneous neuroendocrine carcinoma.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Hepatocellular carcinoma as a keyword and updated the site revision to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.